ctibiopharma.com

Cti Biopharma

Cti Biopharma's email is info@askarm.com .

CTI BioPharma Corp. a biopharmaceutical company, develops, acquires, and commercializes oncology products for cancer treatment. Its development portfolio includes Pixantrone, a phase III trial product, for non-Hodgkin's lymphoma; Brostallicin, which is in first-line Phase II study for the treatment of sarcoma; and OPAXIO, a chemotherapeutic agent for the potential treatment of non-small cell lung, ovarian, and other cancers. It has collaboration and licensing arrangements with Novartis International Pharmaceutical, Ltd.; and PG-TXL Company, L.P.
View Top Employees for Cti Biopharma
img Website ctibiopharma.com
img Industry Biotechnology
img Location Seattle, Washington, United States
img Employees 124
img Founded 1992
img HQ 501 Elliott Ave. W. Suite 400
img Email info@askarm.com
img Funding 185,760,000 USD
img Competitors Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences,
img Website ctibiopharma.com
img Industry Biotechnology
img Location Seattle, Washington, United States
img Employees 124
img Founded 1992
img LinkedIn linkedin.com/company/cell-therapeutics-inc.
img HQ 501 Elliott Ave. W. Suite 400
img Email info@askarm.com
img Funding 185,760,000 USD

Top Cti Biopharma Employees